Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
NCT02816710
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
112
Enrollment
OTHER
Sponsor class
Conditions
Proliferative Diabetic Retinopathy
Tractional Retinal Detachment
Interventions
DRUG:
Conbercept
Sponsor
Ruijin Hospital